UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 768

Sortiert nach

Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study

Annals of oncology, 2017-03, Vol.28 (3), p.634-641

2017

Link zum Volltext

Verfügbarkeit prüfen

How I treat brain metastases of melanoma

ESMO open, 2022-12, Vol.7 (6), p.100598-100598, Article 100598

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer

Journal of clinical oncology, 2001-02, Vol.19 (3), p.843-850

2001

Link zum Volltext

Verfügbarkeit prüfen

Phase Ib Trial of Intravenous Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor in Combination With Chemotherapy in Patients With Advanced Cancer: Pharmacologic and Long-Term Safety Data

Journal of clinical oncology, 2001-02, Vol.19 (3), p.851-856

2001

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States

ESMO open, 2021-10, Vol.6 (5), p.100252-100252, Article 100252

2021

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors

Annals of oncology, 2015-10, Vol.26 (10), p.2125-2132

2015

Link zum Volltext

Verfügbarkeit prüfen

A personal neoantigen vaccine, NEO-PV-01, with anti-PD1 induces broad de novo anti-tumor immunity in patients with metastatic melanoma, NSCLC, and bladder cancer

Annals of oncology, 2018-10, Vol.29, p.viii400-viii400

2018

Link zum Volltext

Verfügbarkeit prüfen

Effects of Interleukin-12 on the Immune Response to a Multipeptide Vaccine for Resected Metastatic Melanoma

Journal of clinical oncology, 2001-09, Vol.19 (18), p.3836-3847

2001

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-2 in the treatment of renal cancer

Seminars in oncology, 2000-04, Vol.27 (2), p.194

Margolin, K A

2000

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors

Annals of oncology, 2015-12, Vol.26 (12), p.2507-2508

2015

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’: [ESMO Open Volume 6, Issue 5, October 2021, 100252]

ESMO open, 2021-12, Vol.6 (6), p.100286-100286, Article 100286

2021

Link zum Volltext

Verfügbarkeit prüfen

22LBA Activity of PD-1 blockade with pembrolizumab as first systemic therapy in patients with advanced Merkel cell carcinoma

European journal of cancer (1990), 2015-09, Vol.51, p.S720-S721

2015

Link zum Volltext

Verfügbarkeit prüfen

Health Care Costs in Patients Treated with Ipilimumab for Advanced Melanoma Results of a Retrospective Chart Review

Value in health, 2014-11, Vol.17 (7), p.A615-A615

2014

Link zum Volltext

Verfügbarkeit prüfen

High Dose Chemotherapy and Stem Cell Support in the Treatment of Germ Cell Cancer

The Journal of urology, 2003-04, Vol.169 (4), p.1229-1233

MARGOLIN, KIM

2003

Link zum Volltext

Verfügbarkeit prüfen

Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group

Journal of cancer research and clinical oncology, 2002-04, Vol.128 (4), p.214-218

2002

Link zum Volltext

Verfügbarkeit prüfen

Synergistic Effect of TVEC and Radiotherapy in the Treatment of Advanced Melanoma

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e342-e342

2023

Link zum Volltext

Verfügbarkeit prüfen

9306 ORAL Safety and Efficacy of Ipilimumab-treated Patients With Melanoma and Brain Metastases

European journal of cancer (1990), 2011, Vol.47, p.S654-S654

2011

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy

Journal of clinical oncology, 2010-11, Vol.28 (33), p.4906-4911

2010

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Interleukin 2, Interferon α, and 5-Fluorouracil in Metastatic Renal Cell Cancer: A Cytokine Working Group Study

Clinical cancer research, 2000-09, Vol.6 (9), p.3442-3450

2000

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma

Journal of clinical oncology, 1993-04, Vol.11 (4), p.661-670

1993

Link zum Volltext

Verfügbarkeit prüfen

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

The New England journal of medicine, 2011-06, Vol.364 (26), p.2507-2516

2011

Link zum Volltext

Verfügbarkeit prüfen

Outpatient Biochemotherapy With Interleukin-2 and Interferon Alfa-2b in Patients With Metastatic Malignant Melanoma: Results of Two Phase II Cytokine Working Group Trials

Journal of clinical oncology, 2001-07, Vol.19 (13), p.3194-3202

2001

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis

Cancer chemotherapy and pharmacology, 2000, Vol.46 (1), p.19-26

2000

Link zum Volltext

Verfügbarkeit prüfen

CCI-779 in metastatic melanoma : A phase II trial of the california cancer consortium

Cancer, 2005-09, Vol.104 (5), p.1045-1048

2005

Link zum Volltext

Verfügbarkeit prüfen

LBA-4 Results from an expanded phase 1 trial of botensilimab (BOT), a multifunctional anti-CTLA-4, plus balstilimab (BAL; anti-PD-1) for metastatic heavily pretreated microsatellite stable colorectal cancer (MSS CRC)

Annals of oncology, 2023-06, Vol.34, p.S178-S179

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 768

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(680)
Mit Volltextzugriff
(650)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(485)
Life Sciences & Biomedicine
(433)
Humans
(407)
Female
(298)
Adult
(237)
Male
(231)
Middle Aged
(227)
Biological And Medical Sciences
(211)
Medical Sciences
(204)
Oncology
(197)
Aged
(144)
Pharmacology. Drug Treatments
(92)
Treatment Outcome
(82)
Medicin Och Hälsovetenskap
(81)
Antineoplastic Agents
(75)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(75)
Chemotherapy
(59)
Breast Cancer
(58)
Tumors
(55)
Adolescent
(48)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study

How I treat brain metastases of melanoma

Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer

Phase Ib Trial of Intravenous Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor in Combination With Chemotherapy in Patients With Advanced Cancer: Pharmacologic and Long-Term Safety Data

Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States

Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors

A personal neoantigen vaccine, NEO-PV-01, with anti-PD1 induces broad de novo anti-tumor immunity in patients with metastatic melanoma, NSCLC, and bladder cancer

Effects of Interleukin-12 on the Immune Response to a Multipeptide Vaccine for Resected Metastatic Melanoma

Interleukin-2 in the treatment of renal cancer

Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors

Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’: [ESMO Open Volume 6, Issue 5, October 2021, 100252]

22LBA Activity of PD-1 blockade with pembrolizumab as first systemic therapy in patients with advanced Merkel cell carcinoma

Health Care Costs in Patients Treated with Ipilimumab for Advanced Melanoma Results of a Retrospective Chart Review

High Dose Chemotherapy and Stem Cell Support in the Treatment of Germ Cell Cancer

Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group

Synergistic Effect of TVEC and Radiotherapy in the Treatment of Advanced Melanoma

9306 ORAL Safety and Efficacy of Ipilimumab-treated Patients With Melanoma and Brain Metastases

Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy

Phase II Trial of Interleukin 2, Interferon α, and 5-Fluorouracil in Metastatic Renal Cell Cancer: A Cytokine Working Group Study

Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

Outpatient Biochemotherapy With Interleukin-2 and Interferon Alfa-2b in Patients With Metastatic Malignant Melanoma: Results of Two Phase II Cytokine Working Group Trials

Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis

CCI-779 in metastatic melanoma : A phase II trial of the california cancer consortium

LBA-4 Results from an expanded phase 1 trial of botensilimab (BOT), a multifunctional anti-CTLA-4, plus balstilimab (BAL; anti-PD-1) for metastatic heavily pretreated microsatellite stable colorectal cancer (MSS CRC)

Suchergebnisse filtern